C. Michael White, Pharm.D., FCP, FCCP, FASHP
Distinguished Professor and Chair, Pharmacy Practice, UConn School of Pharmacy
Wed, Sept 25, 2024 – Live Webinar
10 am – 11:30 am
1.5 CECs
Registration Fee: $37.50
10% discount for UConn SSW Alumni and Current SSW Field Instructors
C. Michael White, Distinguished Professor and Chair, Pharmacy Practice at the UConn School of Pharmacy, will discuss the clinical evidence behind psychedelic treatments for mental health disorders. While more research is needed on the effectiveness of psychedelics in the treatment of anxiety, depression, trauma, substance use, and other mental health disorders, Dr. White will discuss and clarify their potential therapeutic benefits and risks.
At the conclusion of this lecture, the participants will be able to:
- Describe the similarities of common mental health disorders and the mechanisms of action for current pharmacologic treatment options and psychedelics.
- Describe the pooled impact of psychedelics on mental health disorders and the strength of evidence for benefit.
- Describe the potential implications for treating patients with psychedelics for mental health disorders and what are the risks (including risks of self-medicating with illicit products)
- Describe the unique role of social workers when dealing with patients who have mental health disorders if psychedelics are a treatment option
- Describe what legal hurdles need to be overcome